FCGR3A and neoplasm: Moreover, where NK cells were identified, expression of CD16a appeared consistently lower on tumor-infiltrating subsets (mean percentage of CD16+ in tumor 41.6% versus blood 81.1%, p < 0.05, Figure 2D).